Early intervention before disease progression using glyhealth
Longevity Technology - 08-Dec-2020Avenna's glyhealth alerts practitioners about subclinical chronic inflammation
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Biotech startup focused on fast-track prognosis, diagnosis and treatments for chronic inflammatory diseases (CIDs), extend lives
Avenna is a BioTech startup specialised in inflammatory conditions.
Avenna is leading the development of practical and affordable preventative precision healthcare solutions, allowing healthy humans and chronic patients to live healthier and longer lives.
Mission is to fast-track prognosis, diagnosis and treatments for individuals with chronic inflammatory diseases (CIDs), increasing their quality of life, extending their lives, and reducing the cost of their care
Visit website: https://avenna.com/
Details last updated 09-Dec-2020
Avenna's glyhealth alerts practitioners about subclinical chronic inflammation